Skip to main content
SpringerLink
Log in

Do recombinant human erythropoietin and iron supplementation increase the risk of retinopathy of prematurity?

  • RESEARCH LETTERS
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Division of Neonatology, Catholic University of Rome, Largo A. Gemelli, 8, 00168 Rome, Italy e-mail: cromagnoli@rm.unicatt.it Tel.: +39-6-30154348; Fax: +39-6-3055301, , , , , , IT

    Constantino Romagnoli, Enrico Zecca, Francesca Gallini, Pietro Girlando & Antonio Alberto Zuppa

Authors
  1. Constantino Romagnoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Enrico Zecca
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Francesca Gallini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pietro Girlando
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Antonio Alberto Zuppa
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Received: 26 October 1999 / Accepted: 9 February 2000

Rights and permissions

Reprints and permissions

About this article

Cite this article

Romagnoli, C., Zecca, E., Gallini, F. et al. Do recombinant human erythropoietin and iron supplementation increase the risk of retinopathy of prematurity?. Eur J Pediatr 159, 627–628 (2000). https://doi.org/10.1007/PL00008390

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/PL00008390

Keywords

Search

Navigation